DKBmed Podcasts – Medical Education Podcasts
DKBmed Radio episodes
Volume 2, Issue 6
In this podcast, Drs. Daniel Ontaneda, Jenny Feng and Gabrielle Macaron from the Cleveland Clinic follow up on their recent eMS Newsletter Issue (V2; No.5) to discuss some of the practical applications of individualizing MS therapy.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (emultiplesclerosis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 8, Issue 9.
In this issue:
The effects of CFTR modifiers on improving lung function in people with cystic fibrosis are well known. But what about their effects on the GI tract that directly affect nutrition?
In this issue, Dr. Michael Wilschanski — Director of Hadassah Hospital’s Pediatric Gastroenterology Unit at Hebrew University in Jerusalem — explains how new findings about CFTR modification can impact clinical practice.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (ecystic): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 1, Issue 2
In this issue:
PrEP — pre-exposure prophylaxis to prevent HIV transmission — is safe, it’s effective, and it’s significantly underused in the U.S. One key barrier to increased PrEP use is a lack of awareness and acceptance among the patient populations most at-risk for new HIV infection.
In this podcast, Dr. Douglas Krakower from Harvard Medical School takes us into the exam room to translate the new information in his Newsletter Issue into clinical practice.
Take our post-test to claim CME credits.
To read a companion newsletter click here
Podcast (eprimarycarereview): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 4, Issue 10
In this Issue, Dr. Joyce Jones from the Johns Hopkins University School of Medicine and Dr. Barbara Taylor from the University of Texas Health Science Center at San Antonio analyze recent publications describing evidence-based ART adherence interventions and how they can be tailored to specific situations to increase effectiveness.
Take our post-test to claim CME credits.
To read a companion newsletter click here
Podcast (ehiv): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 2, Issue 4
In this issue, Dr. Ellen Mowry, Associate Professor of Neurology and Epidemiology at the Johns Hopkins University School of Medicine, brings recent findings about patient decision-making and addressing common comorbidities into the MS clinic.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (emultiplesclerosis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 4, Issue 8
While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmarketing surveillance has identified important adverse effects not found in the clinical trial populations.
In this issue, Dr. Cody Chastain from the Division of Infectious Diseases at Vanderbilt University Medical Center discusses how these new findings can impact the clinical use of these new agents.
Take our post-test to claim CME credits.
To read a companion newsletter click here
Podcast (ehiv): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 8, Issue 6.
In this issue, Dr. Gregory Sawicki — Associate Professor of Pediatrics at Harvard Medical School and Director of the Cystic Fibrosis Center at Boston Children’s Hospital — discusses how the recent findings about the real-world use of CFTR modulators can impact clinical practice.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (ecystic): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 2, Issue 2
The central vein sign. Optical coherence tomography. Serum neurofilament light chain. New research has identified these markers as valuable in discriminating MS from mimicking conditions, and in predicting future disability.
In this Issue, Dr. Michael Kornberg and Dr. Elias Sotirchos from the Johns Hopkins University School of Medicine discuss how these advances can impact clinical decision-making to provide better patient care.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (emultiplesclerosis): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 4, Issue 6.
Linking high-risk populations like PWIDs (people who inject drugs) and MSM (men who have sex with men) to effective HIV care requires overcoming complex barriers unique to these groups.
In this issue, two of the directors from Boston’s Health Care for the Homeless Program, Dr. Jennifer Brody, Director of HIV Services and ANP Marguerite Beiser, Director of HCV Services, discuss the clinical aspects of addressing these challenges.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (ehiv): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Volume 8, Issue 4.
Multidrug resistant lung infections present an increasingly common and increasingly dangerous threat to all individuals with cystic fibrosis. Common CF pathogens — Pseudomonas aeruginosa, Burkholderia cepacia complex, Achromobacter xylosoxidans, Stenotrophomonas maltophilia — are all showing increasing resistance to clinicians’ usual antibiotic armamentarium.
In this issue, Dr. Claire Elson, from the University of Missouri Kansas City School of Pharmacy, and Dr. Christopher Oermann, from the UMKC School of Medicine, describe strategies for the clinical management of these resistant infections.
Take our post-test to claim CME credits.
To read a companion newsletter click here.
Podcast (ecystic): Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS